Downtrend: A logo of Sun Pharmaceutical Industries Ltd is pictured at its research and development centre in Mumbai, India. In August, the world’s largest copycat drugmaker, Israel’s Teva Pharmaceutical Industries Ltd, slashed its dividend; US giant Mylan NV lowered its profit target; and Sun Pharmaceutical reported its first quarterly loss in at least 12 years. — Reuters
Family-owned drugmakers driving price war
MUMBAI: The most recent earnings reports across the generic drug industry have read like dispatches from the front lines of a price war.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
